Apart from the ER or HER2 status of the primary tumor,8 genomic markers9, 10 and the presence of tumor‐infiltrating lymphocytes (TILs)11, 12, 13 have been reported to affect the likelihood of pCR. The gene discussed is ERBB2; the disease is neoplasm.